Net Cash Provided by (Used in) Investing Activities in USD of Nabriva Therapeutics plc from 2015 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Nabriva Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Investing Activities history and change rate from 2015 to Q1 2023.
  • Nabriva Therapeutics plc Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2023 was -$3K, a 91.7% increase year-over-year.
  • Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$263K, a 225% decline from 2021.
  • Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$81K, a 70.4% increase from 2020.
  • Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$274K, a 183% decline from 2019.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

Nabriva Therapeutics plc Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$3K +$33K +91.7% 01 Jan 2023 31 Mar 2023 10-Q 22 May 2023
Q1 2022 -$36K +$84K +70% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023
Q1 2021 -$120K -$100K -500% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q1 2020 -$20K +$22K +52.4% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q1 2019 -$42K +$118K +73.8% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q1 2018 -$160K -$10.1M -102% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q1 2017 $9.98M 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018

Nabriva Therapeutics plc Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$263K -$182K -225% 01 Jan 2022 31 Dec 2022 10-K 17 Apr 2023
2021 -$81K +$193K +70.4% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023
2020 -$274K -$605K -183% 01 Jan 2020 31 Dec 2020 10-K 17 Apr 2023
2019 $331K +$4.94M 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2022
2018 -$4.6M -$54.4M -109% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2021
2017 $49.7M +$26.4M +113% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020
2016 $23.4M +$100M 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019
2015 -$76.7M 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.